Abstract
The phenotypic expressions of rosacea have been suggested to be caused by divergent pathogenetic factors. Although its precise etiology remains unknown, various factors have been suspected of contributing to this condition (Table 81.1). Recently, familial cases of rosacea have been reported, and a genetic predisposition to the disease has been suggested. In addition, ultraviolet (UV) light-induced skin changes, such as solar elastosis and vessel dilatation as well as immunosuppression, have been accused to contribute in the development of rosacea [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Powell FC. Clinical practice. Rosacea. N Engl J Med. 2005;352:793–803.
Plewig G, Kligman AM. Acne and rosacea. Berlin: Springer; 2000. p. 433–75.
Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51:327–41.
Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev. 2000;21:457–87.
Weissenbacher S, Merkl J, Hildebrandt B, et al. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. Br J Dermatol. 2007;156:728–32.
Powell FC, Corbally N, Powell D. Substance P and rosacea. J Am Acad Dermatol. 1993;28:132–3.
Lonne-Rahm S, Nordlind K, Edström DW, et al. Laser treatment of rosacea: a pathoetiological study. Arch Dermatol. 2004;140:1345–9.
Wollina U. Rhinophyma-unusual expression of simple-type keratins and S100A in sebocytes and abundance of VIP receptor-positive dermal cells. Histol Histopathol. 1996;11:111–5.
Kligman AM. A personal critique on the state of knowledge of rosacea. Dermatology. 2004;208:191–7.
Murphy GM. Ultraviolet light and rosacea. Cutis. 2004;74:32–4.
Berg M, Liden S. An epidemiological study of rosacea. Acta Dermatol Venereol. 1989;69:419–23.
Yano K, Kadoya K, Kajiya K, et al. Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1. Br J Dermatol. 2005;152:115–21.
Smith JR, Lanier VB, Braziel RM, et al. Expression of vascular endothelial growth factor and its receptors in rosacea. Br J Ophthalmol. 2007;91:226–9.
Aubin F. Mechanisms involved in ultraviolet light-induced immunosuppression. Eur J Dermatol. 2003;13:515–23.
Lachgar S, Charvéron M, Gall Y, et al. Inhibitory effects of retinoids on vascular endothelial growth factor production by cultured human skin keratinocytes. Dermatology. 1999;199:25–7.
Kosmadaki MG, Yaar M, Arble BL, et al. UV induces VEGF through a TNF-alpha independent pathway. FASEB J. 2003;17:446–8.
Howell BG, Wang B, Freed I, et al. Microarray analysis of UVB-regulated genes in keratinocytes: downregulation of angiogenesis inhibitor thrombospondin-1. J Dermatol Sci. 2004;34:185–94.
McKenzie RC. Ultraviolet radiation B (UVB)-induction of leukaemia inhibitory factor (LIF) in human keratinocytes. Photodermatol Photoimmunol Photomed. 2001;17:284–5.
Buckman SY, Gresham A, Hale P. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis. 1998;19:723–9.
Motley RJ. The significance of telangiectasia in rosacea. In: Marks R, Plewig G, editors. Acne and related disorders. London: Martin Dunitz; 1989. p. 339–44.
Helm KF, Menz J, Gibson LE, et al. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol. 1991;25:1038–43.
Nakamuro K, Johnson WC. Ultraviolet light induced connective tissue changes in rat skin: a histologic and histochemical study. J Invest Dermatol. 1968;51:194–8.
Neumann E, Fritz A. Capillaropathy and capillaroneogenesis in the pathogenesis of rosacea. Int J Dermatol. 1998;37:263–6.
Ramelet A, Perroulaz G. Rosacée: étude histopathologique de 75 cas. Ann Dermatol Venereol. 1988;115:801–6.
Ozkaya-Bayazit E, Buyukbabani N. Anular elastolytic giant cell granuloma sparing a burn scar and successful treatment with chloroquine. Br J Dermatol. 1999;140:525–30.
Al-Hoqail IA, Al-Ghamdi AM. Actinic granuloma is a unique and distinct entity. Am J Dermatopathol. 2002;24:209–12.
Aroni K, Tsagroni E, Lazaris AC, et al. Rosacea: a clinicopathological approach. Dermatology. 2004;209:177–82.
de Wied D. Peptide hormones and neuropeptides: birds of a feather. Trends Neurosci. 2000;23:113–4.
Sleijffers A, Herreilers M, van Loveren H. Ultraviolet B radiation induces upregulation of calcitonin gene-related peptide levels in human Finn chamber skin samples. J Photochem Photobiol. 2003;69:149–52.
Legat FJ, Jaiani LT, Wolf P, et al. The role of calcitonin gene-related peptide in cutaneous immunosuppression induced by repeated subinflammatory ultraviolet irradiation exposure. Exp Dermatol. 2004;13:242–50.
Wilkins BW, Chung LH, Tublitz NJ, et al. Mechanisms of vasoactive intestinal peptide-mediated vasodilation in human skin. J Appl Physiol. 2004;97:1291–8.
Pierard-Franchimont C, Quatresooz P, Piérard GE. Incidental control of rosacea by somatostatin. Dermatology. 2003;206:249–51.
Bamford JT, Elliott BA, Haller IV. Tacrolimus effect on rosacea. J Am Acad Dermatol. 2004;50:107–8.
Shanler SD, Ondo AL. Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist oxymetazoline. Arch Dermatol. 2007;143:1369–71.
Moore A, Kempers S, Murakawa G, et al. Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study. J Drugs Dermatol. 2014;13:56–61.
Del Rosso JQ. Recently approved systemic therapies for acne vulgaris and rosacea. Cutis. 2007;80:113–20.
Park H, Del Rosso JQ. Use of oral isotretinoin in the management of rosacea. J Clin Aesthet Dermatol. 2011;4:54–61.
Grammatopoulos DK, Chrousos GP. Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab. 2002;13:436–44.
Slominski A, Wortsman J, Luger T, et al. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev. 2000;80:979–1020.
Zouboulis CC, Seltmann H, Hiroi N, et al. Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA. 2002;99:7148–53.
Slominski A, Zbytek B, Szczesniewski A, et al. CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab. 2005;288:701–6.
Flint MS, Morgan JB, Shreve SN, et al. Restraint stress and corticotropin releasing hormone modulation of murine cutaneous POMC mRNA. Stress. 2003;6:59–62.
Crompton R, Clifton VL, Bisits AT, et al. Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways. J Clin Endocrinol Metab. 2003;88:5427–32.
Theoharides TC, Donelan JM, Papadopoulou N, et al. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci. 2004;25:563–8.
Donelan J, Boucher W, Papadopoulou N, et al. Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci U S A. 2006;103:7759–64.
Park HJ, Kim HJ, Lee JH, et al. Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway. J Invest Dermatol. 2005;124:751–5.
Zbytek B, Slominski AT. Corticotropin-releasing hormone induces keratinocyte differentiation in the adult human epidermis. J Cell Physiol. 2005;203:118–26.
Krause K, Schnitger A, Fimmel S, et al. Corticotropin-releasing hormone skin signalling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res. 2007;39:166–70.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fimmel, S., Kutzner, H., Zouboulis, C.C. (2014). The Vascular Concept. In: Zouboulis, C., Katsambas, A., Kligman, A. (eds) Pathogenesis and Treatment of Acne and Rosacea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_81
Download citation
DOI: https://doi.org/10.1007/978-3-540-69375-8_81
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69374-1
Online ISBN: 978-3-540-69375-8
eBook Packages: MedicineMedicine (R0)